Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Indian Today/ 21/ 09/ 09 http://indiatoday.intoday.in/site/story?sId=61050&secid=30 The great Indian gene findings Raj Chengappa Who were the first Indians? Were they the chocolate-hued Dravidian southerners or the darkskinned tribals that inhabit East India and the Andaman islands? Was the relatively fair IndoEuropean population of the North the original settler? Or did the Mongoloid-featured Tibetan-Burmans beat the rest to it? When and how did the pioneers reach India? What routes did they take? The answers to these questions have always been the subject of contentious debate and till recently well nigh impossible to conclude. After all today there are more than a billion Indians consisting of 4,693 communities, 4,500 endogamous groups, 325 functioning languages and 25 scripts. Not to mention the four main castes and the hundreds of sub-castes that throw up even more controversial questions such as: Are the Brahmins from a different genetic pool than that of the Shudras? Now an unprecedented surge in genetic research across the country is overturning long-held theories and coming out with some fascinating revelations of how Indians became, well, Indians. Equally significant and directly relevant to the quality of life, for the first time, major genetic studies are underway at a clutch of top national laboratories, which when complete will help us know if any of us run a higher risk of being afflicted with life-threatening diseases such as cancer, diabetes, malaria, cardio-vascular blocks, neurological disorders and asthma. And possibly help in ushering a revolution in healthcare. Blame gene Recent studies show that some Indians exhibit genetic variations that make them susceptible to specific diseases. Malaria: East and Central India populations were found to have a gene that makes them susceptible to 4,693 cerebral malaria. Cancer: Initial studies have found certain populations in the extremes to have higher risk of cancer. Immune response: Indians showed varying immune response to certain drugs holding the key for future treatment. Heart diseases: North Indian vegetarians were more susceptible to heart diseases. Among the more striking results is the finding that Indians are the global melting pot of human diversity containing every possible known genotype. That it is now clear that India was the first stop made by early settlers after the first known human populations migrated out of Africa. That the tremendous genetic diversity originated in the sub-continent itself rather than as a result of the so-called 'Aryan invasion' that historians have theorised about. That some regions in Northern India are more susceptible to heart diseases while some populations in Rajasthan and Jammu have a genetic immunity that puts them at lower risk of HIV infections. The trigger for Indian researchers has been the most spectacular scientific achievement since man walked on the moon: deciphering the book of human life. In 2001, the international Human Genome Project (HGP) came out with a raw translation of the 3 billion strands of DNA-deoxyribonucleic acid-the basic building blocks of all life. To understand the complexity of the effort, if the genome sequence obtained for a single human being were to be published in typed form as books these would stack up as tall as Delhi's Qutab Minar. What the HGP did show was that the human genetic code or genome is 99.9 per cent identical in all people. It was in line with the theory that we all had a common ancestry with the earliest humans who lived in Africa and possibly to a single woman, the "mitochrondial Eve." The 0.1 difference in DNA sequencing is responsible for our individual differences whether in hair or eye colour or our susceptibility to diseases. The project revealed that humans have around 25,000 genes-the basic physical and functional units of heredity. Since then scientists have been able to decode the role played in 50 per cent of the known genes. The unravelling of the human genetic structure is helping researchers worldwide find the most fundamental answers to our origins and in enhancing healthcare. mospagebreak In India, genetic research got a major boost in 2003 when the Council of Scientific and Industrial Research (CSIR), with funding from the government, launched the Indian Genome Variation (IGV) consortium consisting of seven major laboratories: the Institute of Genomics and Integrative Biology (IGIB), Delhi, Centre for Cellular and Molecular Biology (CCMB), Hyderabad, Indian Statistical Institute (ISI), Kolkata, Central Drug Research Institute (CDRI), Lucknow, Institute of Microbial Technology (IMTECH), Chandigarh, Industrial Toxicological Research Centre (ITRC), Lucknow and Indian Institute of Chemical Biology (IICB), Kolkata. The team first collected blood samples of 2,000 people from 55 populations representing the four major linguistic groups: Austro-Asiatic, Tibeto-Burman, Indo-European and Dravidian before splicing their genes and looking for tell-tale variations. In doing so the project established the first large-scale database of genomic diversity in the Indian population. Samir Brahmachari, a geneticist of repute and CSIR's director-general says, "India is among the first country to do a diseases-specific, drug-response mapping on large populations which gives us risk analysis and benefits." Apart from reinforcing what Brahmachari calls the "genetic mosaic" of India, the study also showed that the risk of susceptibility to a disease was more specific to a geographical region rather than to caste, creed or linguistic affinities. Reviewing the consortium's work, Evelyne Heyer, geneticist at the French Natural History Museum, said, "This study forms a valuable first step in building our knowledge of the genetic diversity in India." While the consortium released its preliminary findings last year, since then individual laboratories have come out with a host of important findings. At the CDRI, geneticist Saman Habib focused on the more lethal form of cerebral malaria caused by the Plasmodium falciparum. Studies were conducted on people who lived in the regions where malaria was endemic. Analysing the samples and also from control groups, Habib found a "clear indication of variety of genes affecting the susceptibility of the individual towards this deadly form of malaria including the severity of the attack". One pointer: Health officials would be well-advised to double their efforts in regions with such susceptibility. At the IGIB, Shantanu Sengupta is coming out with surprising findings about cardiovascular diseases and genetic factors. Contrary to popular notions, vegetarians in India have a high susceptibility to heart diseases. That is now found to be due to a deficiency of Vitamin B12. But there was a significant variation of this phenomenon between North and South India. Shompen tribals of the Andaman And Nicobar Islands. The study found that Northern Indians who were also vegetarian had a much higher degree of susceptibility to heart problems than their southern brethren because of a genetic variation that made them vulnerable. The deficiency in Vitamin B12 and the genetic variation increased the level of an amino acids associated as a risk factor for cardiovascular disease. In a laboratory not far from Sengupta, Balaram Ghosh, Head of the Genomics and Molecular Medicine Unit, IGIB is proving just how useful the emerging field known as pharmacogenomics could be. Researching on the cause of asthma in India, his team, after examining over 700 patients, found that many genetic variations that are known to make people susceptible to asthma among European populations were not seen among Indians. They were also able to identify a novel gene that is associated with asthma among Indian patients. These would help them identify high-risk individuals and also advise them on preventive steps. Carrying the process forward, the team studied the absorptive ability of populations to the drug salbutamol used to treat asthma. In some people it was found to be not as effective as in others. Understanding the process would help in administering the right amount of doses of the drug and getting away from "the one-size-fits-all" approach. Somewhat similar work is being done on Diabetes Type II by his colleague Dwaipayan Bharadwaj who is looking for genetic markers that could help doctors identify those susceptible to it long before they come in for treatment. Again here, after examining over 7,000 patients suffering from this type of diabetes, Bharadwaj's study shows that while Indians did have some main gene markers that Europeans had, large amount of them were absent too. mospagebreak The hope is that if they could home in on genetic markers for Diabetes Type II they could warn those Indians at risk early to enable them to take preventive measures and improve their quality of life. Such is the promise of pharmacogenomics that Brahmachari says: "We should soon be able to do rapid tests to determine a patient's genotype and then guide treatment with the most effective drugs apart from reducing adverse reactions." There is also the growing clamour to resort to gene therapy or the potential of using genes themselves to treat disease or enhance particular traits much like the research into stem cells. While genetics holds up the promise of revolutionising health care, there is need to be cautious about its use. Genetic profiling would reveal some of the innermost secrets that could, for instance, be used by employers to weed out candidates found to be susceptible to certain ailments or diseases. "We deliberately didn't release details of the communities in our studies because of the social ramifications involved," says Mitali Mukerji, IGV consortium co-ordinator. So before you go out and get your genes sequenced-it costs around Rs 2.5 lakh abroad-know the benefits and the cost. Experts speak Gene analysis at a Delhi laboratory "India is the first country to do a disease-specific drug-response mapping on large populations. It will give us a risk analysis and also the benefits." Samir Brahmachari Director-General, CSIR "The tribals of India, especially those living in The Andamans, hold the clue to not just who were the earliest Indians but also the origin of man itself." Lalji Singh Former Director, CCMB "South Asia played a pivotal role in the out-of-Africa colonisation and dispersal of modern humans." Partha P. Majumder Head of Human Genetics Unit, ISI "There is a clear indication of a variety of genes affecting the susceptibility of the individual towards lethal cerebral malaria." Saman Habib Scientist, CDRI "The best way to understand the Indian gene pool is to compare it to a large banyan tree which has a trunk with branches than twigs and leaves." Ramaswamy Pitchappan Professor Emeritus, Madurai Kamaraj University